Meningioma 1 antibody (Middle Region)
-
- Target See all Meningioma 1 (MN1) Antibodies
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Binding Specificity
- AA 842-872, Middle Region
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This Meningioma 1 antibody is un-conjugated
-
Application
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Specificity
- This antibody recognizes Human MN1 (Center).
- Purification
- Protein A column, followed by peptide affinity purification
- Immunogen
- KLH conjugated synthetic peptide between 842-872 amino acids from the Central region of human MN1.
- Isotype
- Ig Fraction
- Top Product
- Discover our top product MN1 Primary Antibody
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.25 mg/mL
- Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Avoid repeated freezing and thawing.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
- Alternative Name
- MN1 (MN1 Products)
- Background
- Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4,22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.Synonyms: Probable tumor suppressor protein MN1, meningioma 1
- Molecular Weight
- 136001 Da
- Gene ID
- 4330
- NCBI Accession
- NP_002421
-